Yeşim Gülşen-Parman

Association of HLA-DRB1∗14, -DRB1∗16 and -DQB1∗05 with MuSK-myasthenia gravis in patients from Turkey

Vuslat Yılmaz, Yeşim Gülşen-Parman, Fikret Aysal et al. · Human Immunology · 2013 · 52 citations

Autoimmune Disease, Musk-myasthenia Gravis, Pathogenesis +6

Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK

Vuslat Yılmaz, Piraye Oflazer, Fikret Aysal et al. · PLoS ONE · 2015 · 47 citations · Full text

Clinical Immunology, Immunodeficiencies, Cellular Immunology +30

Genetic heterogeneity within the HLA region in three distinct clinical subgroups of myasthenia gravis

Güher Saruhan‐Direskeneli, Travis K. Hughes, Vuslat Yılmaz et al. · Clinical Immunology · 2016 · 42 citations

Mendelian Disorder, Genetic Disorder, Genetics +10

Regulatory function of CD4+CD25++ T cells in patients with myasthenia gravis is associated with phenotypic changes and STAT5 signaling: 1,25-Dihydroxyvitamin D3 modulates the suppressor activity

Piraye Oflazer, Fikret Aysal, Hacer Durmuş et al. · Journal of Neuroimmunology · 2015 · 39 citations

Molecular Physiology, Autoimmune Disease, Stat5 Signaling +9

Muscle magnetic resonance imaging in spinal muscular atrophy type 3: Selective and progressive involvement

Hacer Durmuş, Ravza Yılmaz, Yeşim Gülşen-Parman et al. · Muscle & Nerve · 2016 · 39 citations